Src-/- fibroblasts are defective in their ability to disassemble focal adhesions in response to phorbol ester/hyaluronan treatment.

Cell Commun Adhes 2002 Sep-Dec;9(5-6):273-83

Depts. Oncology and Biochemistry, The University of Western Ontario and London Regional Cancer Center, London, Ontario, Canada N6A 4L6.

Exogenous hyaluronan promotes a rapid recruitment of Src to lamellae of mutant active H-ras transformed fibroblasts and an Src- and RHAMM (CD168)-dependent increase in random motility. These responses are accompanied by a loss of vinculin-positive lamellae focal adhesions. Nontransformed immortalized wild-type fibroblasts (WT) do not increase random motility in response to hyaluronan alone, but do increase motility in response to a combination of PMA treatment followed by hyaluronan. PMA treatment alone increases the number of lamellae/cell, percentage of cells with lamellae and number of focal adhesions/lamellae. Subsequent addition of hyaluronan does not affect the number of lamellae/cell but reduces both the number of focal adhesion/lamellae and the percentage of cells forming focal adhesion-positive lamellae. These effects are prevented by blocking RHAMM antibodies and mimicked by agonist RHAMM antibodies. Src-/- fibroblasts exhibit a limited response to PMA but do not increase motility or disassemble focal adhesions in response to a subsequent addition of HA. Rescue of Src-/- fibroblasts with either SrcA or c-Src restores response to close to WT levels. These results suggest that Src activity is uniquely required for both PMA and PMA-induced hyaluronan regulation of random motility and focal adhesion turnover.

Download full-text PDF

Source
August 2003
6 Reads

Publication Analysis

Top Keywords

random motility
12
focal adhesions
12
src-/- fibroblasts
12
number lamellae/cell
8
percentage cells
8
number focal
8
subsequent addition
8
increase random
8
increase motility
8
adhesions response
8
disassemble focal
8
motility response
8
pma treatment
8
rhamm antibodies
8
focal
7
response
6
motility
5
hyaluronan
5
affect number
4
focal adhesion-positive
4

Similar Publications